Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Securities Commission Malaysia revision could revive more SPACs; Alpha Tau completes enrollment of Japanese pivotal clinical trial
SC’s Revision Could Revive More SPACs in Malaysia
The revised equity guidelines for the enhanced SPAC framework from Jan 1, 2022 are expected to make the asset class a more attractive option for promoters and potential investors.
The revisions announced by the Securities Commission Malaysia (SC) last December provide more management flexibility to SPACs, allowing professionals with extensive experience in private equity and venture capital with asset sourcing and deal making experience to steer SPACs, said Dr Liew Chee Yoong, Assistant Professor of Finance at UCSI University and a Fellow of the Centre for Market Education.
READAlpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has been notified by HekaBio K.K., its clinical trial partner in Japan, that recruitment has been completed in its open-label multi-center pivotal study evaluating the Alpha DaRT in Japanese patients with recurrent Head & Neck cancer after radiotherapy.
HekaBio has reported that preliminary results of this trial are highly encouraging, and that it will continue compilation and analysis of the data in collaboration with its medical experts, in an effort to prepare a submission seeking marketing approval via the shonin pathway in consultation with Japanese authorities.
On July 8, 2021, Alpha Tau announced that it had entered into a definitive merger agreement with Healthcare Capital Corp. (Nasdaq: HCCC).
READ
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...